Iveta Selingerová

11PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 19, 2025
Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trial.

Radka Lordick Obermannova, Iveta Selingerova, Regina Demlova

|Jan 25, 2025
Axillary Overtreatment in Patients with Breast Cancer After Neoadjuvant Chemotherapy in the Current Era of Targeted Axillary Dissection.

Ondřej Zapletal, Jan Žatecký, Lucie Gabrielová

|Mar 29, 2023
FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer.

Peter Grell, Simona Borilova, Pavel Fabian

|Sep 23, 2022
Identification of AGR2 Gene-Specific Expression Patterns Associated with Epithelial-Mesenchymal Transition.

Andrea Martisova, Lucia Sommerova, Adam Krejci

|Jul 27, 2022
Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy.

Milos Holanek, Iveta Selingerova, Pavel Fabian

|Jun 23, 2022
Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)-Exploring Its Possible Clinical Relevance in Cancer Patients.

Michal Rihacek, Iveta Selingerova, Ivo Kocak

Pageof 2

Frequent Collaborators

5 joint publications

Tomas Kazda

4 joint publications

Milos Holanek

2 joint publications

Petr Burkon

2 joint publications

Radka Obermannova